Hyd0a 0011 01
Hydralazine Hydrochloride
Product Images NDC 17478-934
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 17478-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Hyd0a 0011 02
This is a description of a medication called HydrALAZINE Hydrochloride Injection, USP. It is provided in a single dose vial of 1 mL and can be used for intramuscular or intravenous injections. The medication is identified by its NDC code 17478-934-01. The rest of the text appears to be a mixture of characters without any clear meaning.*
Hyd0a 0011 03
Hydralazine Hydrochloride Injection is a medication administered intravenously or intramuscularly. It contains 20 mg per millilitre of the active ingredient, Hydralazine Hydrochloride USP. The solution also contains Propylene Glycol USP, Sodium Hydroxide, and/or Hydrochloric Acid to adjust the pH level, Water for Injection, and preservatives such as Methylparaben NF and Propylparaben NF. The medication can only be used by patients who are unable to take oral medications. The usual dosage is provided in the package insert, and any unused portion should be discarded. Hydralazine Hydrochloride Injection is manufactured by Akorn, Inc. and is sterile and non-pyrogenic.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
